Drug ID: | NPD5338 |
Drug Name: | |
Molecular Formula: | C22H34N2O2 |
Canonical SMILES: | CC(C[C@H]1[C@H](OC(=O)N1CCCN1CCCCCC1)c1ccccc1)C |
Standard InCHI: | InChI=1S/C22H34N2O2/c1-18(2)17-20-21(19-11-6-5-7-12-19)26-22(25)24(20)16-10-15-23-13-8-3-4-9-14-23/h5-7,11-12,18,20-21H,3-4,8-10,13-17H2,1-2H3/t20-,21+/m0/s1 |
Standard InCHIKey: | DQNMZSIJHFEYTM-LEWJYISDSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB008443 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 358.26 |
ALogP | -0.7367 |
MLogP | 3.44 |
XLogP | 6.086 |
HDA | 4 |
HBD | 0 |
Rotatable Bonds | 9 |
TPSA | 32.78 |
RO5 Violation | 1 |